Zika virus Infections - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 177 pages report, published by Global Markets Direct

Report ThumbnailJune-2017
Zika virus Infections - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika virus Infections - Pipeline Review, H1 2017, provides an overview of the Zika virus Infections (Infectious Disease) pipeline landscape.

Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes. Zika virus is a member of the Flaviviridae family. Symptoms include fever, skin rashes, conjunctivitis, muscle and joint pain, mal

Read More
  • List of Figures
  • Number of Products under Development for Zika virus Infections, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1
Read More
  • List of Tables
  • Number of Products under Development for Zika virus Infections, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Produ
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 5
  • Zika virus Infections - Overview 6
  • Zika virus Infections - Therapeutics Development 7
  • Zika virus Infections - Therapeutics Assessment 18
  • Zika virus Infections - Companies Involved in Therapeutics Development 26
  • Zika virus Infections - Drug Profiles 48
  • Zika virus Infections - Dormant Projects 157
  • Zika virus Infections - Product Development Milestones 158
  • Appendix 168
Read More

Please select a license type

Share

Related Products

Global Markets DirectZika virus Infections - Pipeline Review, H1 2017Product ThumbnailZika virus Infections - Pipeline Review, H1 2017, Industry ReportProduct #: 828991
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved